Close Menu
Skip to main content
GenomeWeb
360Dx
Precision Oncology News
360Dx
RSS Feeds
Twitter
LinkedIn
*
*
Show password
Forgot your password?
Subscribe
Contains all of these words:
You may find more results for this query on our sister sites:
GenomeWeb
and
Precision Oncology News
.
Business & Policy
Business News
Research Funding
Policy & Legislation
Regulatory News
Reimbursement
Clinical Lab Management
Diagnostics
Molecular Diagnostics
Immunoassays
Tissue-Based Testing
Clinical Chemistry
Hematology/Coagulation
Point-of-Care Testing
Companion Diagnostics
Disease Areas
Cancer
Infectious Disease
Cardiovascular Disease
Neurological & Psychological Disease
Autoimmune Disease
Inherited Disease
Reproductive Health
Respiratory
Gastrointestinal
Resources
Webinars
White Papers
Job Listings
Conferences & Events
New Products
People in the News
Coronavirus Test Tracker
Menu
Home
›
About Us
›
Our Staff
›
Allan Nixon
Allan Nixon
Director of Business Development, Premium Content
Phone Number
+1-212-651-5623
Email
[email protected]
Breaking
News
FDA Issues Emergency Use Authorization for University of Nebraska Medical Center Coronavirus Test
Oxford Immunotec Shares Rise Sharply on Report of $400M Acquisition Offer
Medix Biochemica Acquires US Firms EastCoast Bio, Biostride
HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing
Opti Medical Systems Gets CE Mark for Coronavirus Test Kit
AACC Revises Guidance on Management of Point-of-Care Testing
Sign Up for Topical Newsletters
